Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China-Reference-Cited by-同舟云学术

Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China

Published:2020-07-27 Issue:3 Volume:87 Page:1155-1164
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Gao Xiang‐Bo¹,Zheng Yi²,Yang Fan²,Wang Chen‐Hong³,Jiang Zhou‐Hong¹,Wu Yue‐E²,Jacqz‐Aigrain Evelyne⁴⁵^ORCID,Ni Shao‐Qing⁶,Zhao Wei²⁷⁸^ORCID

Affiliation:

1. Department of Pharmacy Children's Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang Province China

2. Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine Shandong University Jinan China

3. Department of Neonatal Intensive Care Unit Children's Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang Province China

4. Department of Pediatric Pharmacology and Pharmacogenetics Hôpital Robert Debré, APHP Paris France

5. Sorbonne Paris Cité University Paris Diderot Paris France

6. Clinical Trial Institute Children's Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang Province China

7. Department of Clinical Pharmacy The First Affiliated Hospital of Shandong First Medical University Jinan China

8. Clinical Research Center The First Affiliated Hospital of Shandong First Medical University Jinan China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14483

Reference36 articles.

1. Apnea in premature infants: monitoring, incidence, heart rate changes, and an effect of environmental temperature;Daily WJ;Pediatrics,1969

2. Morbidity and mortality of infants weighing less than 1,000 grams in an intensive care nursery;Alden ERMT;Pediatrics,1972

3. Caffeine Therapy for Apnea of Prematurity

4. Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity

5. Theophylline or Caffeine: Which Is Best for Apnea of Prematurity?

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models;European Journal of Pharmaceutics and Biopharmaceutics;2024-11

2. Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27

3. Modeling Developmental Changes in Caffeine Clearance Considering Differences between Pre- and Postnatal Period;Biological and Pharmaceutical Bulletin;2024-04-20

4. Population Pharmacokinetics of Caffeine in Neonates with Congenital Heart Disease and Associations with Acute Kidney Injury;The Journal of Clinical Pharmacology;2023-11-22

5. A CAFEÍNA COMO DROGA DE PRIMEIRA ESCOLHA NO TRATAMENTO DE RECÉM-NASCIDOS PREMATUROS COM APNEIA;REVISTA FOCO;2023-11-21